featured
-
Gene silencing for HD: the story so far
10 min read
Is gene silencing as exciting as it sounds for HD, and what might the future hold?
-
Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis
7 min read
HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc
-
Interview: CHDI Management
11 min read
HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide
-
CHDI Report: Day 3
8 min read
Day 3 of CHDIās HD therapeutics conference: growth factors and CHDIās advanced therapies
-
CHDI Report: Day 2
5 min read
Day 2 of CHDIās HD therapeutics conference: figuring out energy problems in HD
-
CHDI Report: Day 1
9 min read
Day 1 of CHDIās HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene
-
Welcome to HDBuzz
3 min read
Welcome to HDBuzz. Huntingtonās disease research news. In plain language. Written by scientists. For the global HD co
-
Is Huntingtonās disease twice as common as we thought?
5 min read
New data suggest there may be twice as many people with HD symptoms as previously thought ā and even more at risk
-
Two large HD observational studies ā COHORT and Registry ā merge to create ENROLL-HD
5 min read
Merger of two major Huntingtonās Disease observational trials creates ENROLL-HD
-
Huntexil for symptoms of Huntington's disease: where are we now?
6 min read
Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex